Protection of auditory neurons from aminoglycoside toxicity by neurotrophin-3

Nature Medicine

Volumn 2, Issue 4, 1996, Pages 463-467

  Ernfors, Patrik ^a   Duan, Mao L I ^a   Elshamy, Wael M ^a   Canlon, Barbara ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; NEUROTROPHIN 3; RECOMBINANT NEUROTROPHIN 3; UNCLASSIFIED DRUG;

ACOUSTIC NERVE FIBER; ANIMAL CELL; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; EVOKED BRAIN STEM AUDITORY RESPONSE; GUINEA PIG; INNER EAR; NERVE DEGENERATION; NEUROPROTECTION; NONHUMAN; OTOTOXICITY; PRIORITY JOURNAL; SPINAL GANGLION;

AMINOGLYCOSIDES; ANIMALS; CELL COUNT; CELL DEATH; GUINEA PIGS; HEARING DISORDERS; NERVE GROWTH FACTORS; NEURONS; NEUROTROPHIN 3; SPIRAL GANGLION;

ANIMALIA; CAVIA; CAVIA PORCELLUS; SUS SCROFA;

EID: 19144362852     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm0496-463     Document Type: Article

References (40)

1. Paparella, M.M. & Shumrick, D.A. (eds.) Otolaryvgology. 1817 (Saunders, Philadelphia, 1980).
2. Ernfors, P., Merlio, J.-P. & Persson, H. Cells expressing mRNA for neurotrophins and their receptors during embryonic rat development. Eur. J. Neurosci. 4, 1140-1158 (1992).
3. Pirvola, U. et al. Brain-derived neurotrophic factor and neurotrophin 3 mRNAs in the peripheral target fields of developing inner ear ganglia. Proc. Natl. Acad. Sci. USA 89, 9915-9919 (1992).
4. Ylikoski, J. et al. Expression patterns of neurotrophin and their receptor mRNAs in the rat inner ear. Hear Res. 65, 69-78 (1993).
5. Avila, M.A. et al. Brain-derived neurotrophic factor and neurotrophin-3 support survival and neuritogenesis response of developing cochleovestibular ganglion neurons. Dev. Biol. 159, 266-275 (1993).
6. Davies, A.M., Thoenen, H. & Barde, Y.-A. The response of chick sensory neurons to brain-derived neurotrophic factor. J. Neurosci. 6, 1897-1904 (1986).
7. Lefebvre, P.P. et al. Neurotrophins affect survival and neuritogenesis by adult injured auditory neurons in vitro. Neuroreport 5, 865-868 (1994).
8. Represa, J. et al. Brain-derived neurotrophic factor and neurotrophin-3 induce cell proliferation in the cochleovestibular ganglion through a glycosylphophatidylinositol signaling system. Dev. Biol. 159, 257-265 (1993).
9. Vazquez, E. et al. Pattern of trkB protein-like immunoreactivity in vivo and the in vitro effects of brain-derived neurotrophic factor (BDNF) on developing cochlear and vestibular neurons. Anat. Embryol. (Berl.) 189, 157-67 (1994).
10. Zheng, J.L., Stewart, R.R. & Gao, W.-Q. Neurotrophin-4/5 enhances survival of cultured spiral ganglion neurons and protects them from cisplatin neurotoxicity. J. Neurosci. 15, 5079-5087 (1995).
11. Ernfors, P., Lee, K-F., Kucera, J. & Jaenisch, R. Lack of neurotrophin-3 leads to deficiencies in the peripheral nervous system and loss of limb proprioceptive afferents. Cell 77, 503-512 (1994).
12. Ernfors, P., Van De Water, T.R., Loring, J. & Jaenisch, R. Complementary roles of BDNF and NT-3 in auditory and vestibular development. Neuron 14, 1153-1164 (1995).
13. Farinas, I., Jones, K.R., Backus, C., Wang, X.Y. & Reichardt, L.F. Severe sensory and sympathetic deficits in mice lacking neurotrophin-3. Nature 369, 658-61 (1994).
14. Ernfors, P., Lee, K-F. & Jaenisch, R. Mice lacking brain-derived neurotrophic factor develop with sensory deficits. Nature 368,147-150 (1994).
15. Axdorph, U., Laurell, G. & Björkholm, M. Monitoring hearing during treatment of leukemia with special reference to the use of amikacin. J. Intern. Med. 233, 401-407 (1993).
16. Bichler, E., Spoendlin, H. & Rauchegger, H. Degeneration of cochlear neurons after amikacin intoxication in the rat. Arch. Otorhinolaryngol. 237, 201-208 (1983).
17. Hinojosa, R. & Lerner, S.A. Cochlear neural degeneration without hair cell loss in two patients with aminoglycoside ototoxicity. J. Infect. Dis. 156, 449-455 (1987).
18. Koitchev, K., Guilhaume, A., Cazals, Y. & Aran, J.-M. Spiral ganglion changes after massive aminoglycoside treatment in the guinea pig. Acta Otolaryngol. 94, 431-438 (1982).
19. Kumana, C.R. & Yuen, K.Y. Parenteral aminoglycoside therapy: Selection, ad-ministration and monitoring. Drugs 47, 902-913 (1994).
20. Matz, G.J. Aminoglycoside cochlear toxicity. Otolaryngol. Clin. North Am. 26, 705-712 (1993).
21. Lewin, G.R. & Barde, Y.-A. Physiology of the neurotrophins. Annu. Rev. Neurosci. 19, 289-317 (1996).
22. Crowley, C. et al. Mice lacking nerve growth factor display perinatal loss of sensory and sympathetic neurons yet develop basal forebrain cholinergic neurons. Cell 76, 1001-1011 (1994).
23. Jones, K.R., Farinas, I., Backus, C. & Reichardt, L.F. Targeted disruption of the BDNF gene perturbs brain and sensory neuron development but not motor neuron development. Cell 76, 989-999 (1994).
24. Lewin, G.R. & Mendell, L.M. Nerve growth factor and nociception. Trends Neurosci. 19, 353-359 (1993).
25. Hory-Lee, F., Russel, M., Lindsay, R.M. & Frank, E. Neurotrophin-3 supports the survival of developing muscle sensory neurons in culture. Proc. Natl. Acad. Sci. USA 90, 2613-2617 (1993).
26. Oakley, R.A., Garner, A.S., Largge, T.H. & Frank, E. Muscle sensory neurons require neurotrophin-3 from peripheral tissues during the period of normal cell death. Development 121, 1341-1350 (1995).
27. Arvidsson, J. et al. Effects of NT-3 and TrkC manipulations on developing Merkel innervation in the mystacial pad of the mouse. Soc. Neurosci. abstract (1995).
28. Barbacid, M. The trk family of neurotrophin receptors. J. Neurobiol. 25, 1386-1403 (1994).
29. Henley, C.M. & Ryback, L.P. Developmental ototoxicity. Otolaryngol. Clin. North Am. 26, 857-871 (1993).
30. Tran Ba Huy, P. et al. Pharmacokinetics of gentamicin in perilymph and endolymph of the rat as determined by radioimmunoassay. J. Infect. Dis. 143, 476-486 (1981).
31. Tran Ba Huy, P., Benard, P. & Schacht, J. Kinetics of gentamicin uptake and release in the rat. J. Clin. Invest. 77, 1492-1500 (1986).
32. Luo, L., Koutnouyan, H., Baird, A. & Ryan, A.F. Acidic and basic FGF mRNA expression in the adult and developing rat cochlea. Hear. Res. 69, 182-193 (1993).
33. Pirvola, U. et al. The site of action of neuronal acidic fibroblast growth factor is the organ of Corti of the rat cochlea. Proc. Natl. Acad. Sci. USA 92, 9269-9273 (1995).
34. Thompson, S.W. et al. Cisplatin neuropathy. Cancer 54, 1269-1275 (1984).
35. Estrem, S.A., Babin, R.W., Ryu, J.H. & Moore, K.C. cis-Diamminedichloro-platinum (II) ototoxicity in the guinea pig. Otolaryngol. Head Neck Surg. 89, 638-645 (1981).
36. Fleischman, R.W., Stadnicki, S.W., Ethier, M.F. & Schaeppi, U. Ototoxicity of cis-dichlorodiammine platinum (II) in guinea pig. Toxicol. Appl. Pharinacol. 33, 320-332 (1975).
37. Konishi, T., Gupta, B.N. & Prazma, J. Ototoxicity of cis-dichlorodiammine platinum (II) in guinea pig. J. Otolarygol. 4, 18-26 (1983).
38. Nakai, Y. et al. Ototoxicity of the anticancer drug cisplatin. Acta Otolaryngol. 93, 227-232 (1982).
39. Gao, W.Q. et al. Neurotrophin-3 reverses experimental cisplatin-induced peripheral sensory neuropathy. Ann. Neurol. 38, 30-37 (1995).
40. Canlon, B., Marklund, K. & Borg, E.J. Measures of auditory brain stem responses distortion product otoacoustic emissions, hair cell loss, and forward masked tuning curves in the waltzing guinea pig. J. Acoust. Soc. Am. 94, 1140-1158 (1992).